Search for

Volume 136, Issue 4, Pages 1215-1224.e2 (April 2009)


View previous. 25 of 71 View next.

CME QuizEditorial Accompanies ArticleAdditional Online Content AvailableAlcohol Consumption and the Risks of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus

Australian Cancer StudyNirmala PandeyaCorresponding Author Informationemail address, Gail Williams, Adèle C. Green, Penelope M. Webb, David C. Whiteman

Received 26 August 2008; accepted 18 December 2008. published online 29 December 2008.

Refers to article:
Continuing Medical Education Exam 1, April 2009 , 26 February 2009
Michael B. Wallace
Gastroenterology
April 2009 (Vol. 136, Issue 4, Pages 1444-1445)
Full-Text PDF (91 KB)
Alcohol Drinking and the Risk of Barrett's Esophagus and Esophageal Adenocarcinoma , 23 February 2009
Hashem B. El-Serag, Jesper Lagergren
Gastroenterology
April 2009 (Vol. 136, Issue 4, Pages 1155-1157)
Full Text | Full-Text PDF (232 KB)
Background and Aims

Alcohol has been declared a carcinogen for cancers of the esophagus, although the evidence relates largely to the squamous subtype. Evidence for an effect on adenocarcinomas is scant and inconsistent.

Methods

We compared nationwide samples of patients with esophageal adenocarcinoma (EAC) (n = 365) or esophagogastric junction adenocarcinoma (EGJAC) (n = 426) or esophageal squamous cell carcinoma (ESCC) (n = 303) with controls sampled from a population register (n = 1580). We used generalized additive models to assess nonlinear effects of self-reported alcohol intake on cancer risk, and calculated odds ratios (ORs) and 95% confidence intervals (CIs) using multivariate logistic and piecewise regression.

Results

We observed no association between average weekly alcohol intake and EAC or EGJAC risk. For ESCC, the relationship with alcohol was nonlinear. At intakes of less than 170 g/wk there was no significant association; at greater than this level, there was a significant linear effect (OR, 1.03; 95% CI, 1.02–1.05 per 10 g alcohol/wk). For ESCC, but not EAC or EGJAC, a statistically significant multiplicative interaction between smoking and alcohol was observed (P = .02). In analyses by beverage type, ESCC risks, but not EAC or EGJAC, increased linearly with beer intake (OR, 1.05; 95% CI, 1.04–1.07). Those who drank modest levels of wine (<50–90 g/wk) or port or spirits (<10–20 g/wk) had significantly lower risks of all 3 cancers than nondrinkers; higher intakes were associated with increased risks of ESCC only.

Conclusions

Alcohol intake above the recommended US dietary guidelines significantly increases the risk of ESCC, but not EAC or EGJAC. Smoking modifies the effect of alcohol intake on ESCC risk.

 Queensland Institute of Medical Research, Brisbane, Australia

 School of Population Health, The University of Queensland, Brisbane, Australia

Corresponding Author InformationReprint requests Address requests for reprints to: Nirmala Pandeya, MMedSc, Division of Population Studies and Human Genetics, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland 4029, Australia. fax: (61) 7-3845-3502

 This article has an accompanying continuing medical education activity on page 1444. Learning Objective: Upon completion of this CME activity, successful learners will be able to differentiate the effects of alcohol consumption on the risks of different histologic subtypes of esophageal cancer. Successful learners will also be able to describe the way in which tobacco smoking modifies the effects of alcohol with respect to risk of esophageal cancer.

 Conflict of interest The authors disclose no conflicts.

 Funding This study was supported by the Queensland Cancer Fund and the National Health and Medical Research Council of Australia (program no. 199600). David Whiteman and Penelope Webb are supported by Senior Research Fellowships from the National Health and Medical Research Council of Australia. Nirmala Pandeya is supported by a PhD scholarship from the National Health and Medical Research Council of Australia. The funding bodies played no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.

PII: S0016-5085(08)02310-X

doi:10.1053/j.gastro.2008.12.052


View previous. 25 of 71 View next.